The Impact of Enterococcus spp. in the Immunocompromised Host: A Comprehensive Review

Giuseppe Sangiorgio,Maddalena Calvo,Giuseppe Migliorisi,Floriana Campanile,Stefania Stefani
DOI: https://doi.org/10.3390/pathogens13050409
IF: 3.7
2024-05-16
Pathogens
Abstract:The immunocompromised host is usually vulnerable to infectious diseases due to broad-spectrum treatments and immunological dysregulation. The Enterococcus genus consists of normal gut commensals, which acquire a leading role in infective processes among individuals with compromised immune systems. These microorganisms may express a potential virulence and resistance spectrum, enabling their function as severe pathogens. The Enterococcus spp. infections in immunocompromised hosts appear to be difficult to resolve due to the immunological response impairment and the possibility of facing antimicrobial-resistant strains. As regards the related risk factors, several data demonstrated that prior antibiotic exposure, medical device insertion, prolonged hospitalization and surgical interventions may lead to Enterococcus overgrowth, antibiotic resistance and spread among critical healthcare settings. Herein, we present a comprehensive review of Enterococcus spp. in the immunocompromised host, summarizing the available knowledge about virulence factors, antimicrobial-resistance mechanisms and host-pathogen interaction. The review ultimately yearns for more substantial support to further investigations about enterococcal infections and immunocompromised host response.
microbiology
What problem does this paper attempt to address?
The paper primarily explores the impact of *Enterococcus* spp. on immunocompromised hosts and provides a comprehensive review of research in this field. The core aim of the paper is to understand how *Enterococcus* affects immunocompromised patients, with a focus on its pathogenicity, antibiotic resistance, and mechanisms of interaction with the host. Specifically, the paper attempts to address the following key issues: 1. **Pathogenicity of *Enterococcus***: *Enterococcus* typically exists as a commensal microorganism in the human gut, but it can become a significant pathogen in immunocompromised individuals. The paper explores how these microorganisms express potential pathogenicity and resistance profiles, and how they become serious pathogens in immunocompromised hosts. 2. **Antibiotic Resistance**: Infections caused by *Enterococcus* in immunocompromised hosts are often difficult to treat, partly due to the potential encounter with resistant strains. The paper analyzes the mechanisms of antibiotic resistance in *Enterococcus* and its implications for clinical treatment. 3. **Host-Pathogen Interaction**: The interaction between *Enterococcus* and the host is crucial for understanding the occurrence and development of infections. The paper summarizes existing knowledge on the virulence factors of *Enterococcus*, mechanisms of antibiotic resistance, and the interactions between host and pathogen. Additionally, the paper highlights previous research findings, such as factors like antibiotic exposure, insertion of medical devices, prolonged hospital stays, and surgical interventions that may lead to the overgrowth of *Enterococcus*, antibiotic resistance, and its spread in critical healthcare settings. Finally, the paper calls for more substantial support for further research to better understand *Enterococcus* infections and the response of immunocompromised hosts.